United States· US:72789-251_40ad376a-ff01-ce39-e063-6294a90a7174
Cephalexin
A cefalexin product containing cephalexin, registered in United States by PD-Rx Pharmaceuticals, Inc.. The same ATC class is registered in 14 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Cefalexin is registered in 14 of 19 countries.
Countries holding a registration under ATC J01DB01 (cefalexin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Cefalexin · ATC J01DB01
14 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefalexin costs, country by country.
Normalised to the WHO defined daily dose (2 g), the median price runs from $0.72 in United States to $1.28 in Spain — a ×1.8 gap.
- United States: $0.72 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Cefalexin · price per daily dose (2 g)
USD · FX 28 Sept 2026
- ES Spain$1.28
- US United States$0.72 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Cephalexin
- Manufacturer
- PD-Rx Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- J01DB01
- ATC class
- Cefalexin
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc117278925182500 CAPSULE in 1 BOTTLE, PLASTIC (72789-251-82)
Regulatory notes
Interactions
223 interactions on record for cefalexin.
Graded by severity as the source publishes them — 13 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefalexin · interactions on record
223 records
- 13 moderate
- 210 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- BalsalazideA07EC04moderate
- MetforminA10BA02moderate
- DicoumarolB01AA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefalexin in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCefalexin 500mg capsulesSigma Pharmaceuticals Plc
- SpainCEFALEXINA NORMON 500 mg CAPSULAS DURASLaboratorios Normon S.A.
- CanadaTEVA-CEPHALEXINTEVA CANADA LIMITED
- FinlandXefalAntibiotice SA
- PolandCefaleksyna TZFTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- IrelandKeflex 125 mg/5 ml Powder for Oral SuspensionFlynn Pharma Limited
- GermanyCefalexin Reiwa HealthcareReiwa Healthcare S.L
- ItalyCEPOREX*8 cpr rivestite 1 gTEOFARMA Srl
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Cephalobene, Keflex
- Belgium · Keforal
- Bulgaria · Оспексин
- Cyprus · Felexin, Keflex
- Germany · Cefalexin Reiwa Healthcare, Cephalex-Ct
- Denmark · Keflex
- Spain · Cefalexina Normon, Cefalexina Reiwa Healthcare
- Finland · Kefalex, Kefexin
- France · Keforal, Kéforal
- United Kingdom (Northern Ireland) · Cefalexin, Cefalexin Ascend Laboratories (Uk)
- Croatia · Cefaleksin Belupo, Cefalexin Alkaloid
- Hungary · Cefalexin Reiwa Healthcare, Pyassan 250 Mg Kemény Kapszula
- Ireland · Keflex
- Italy · Ceporex, Keforal
- Luxembourg · Keforal
- Malta · Keflex
- Netherlands · Keforal
- Norway · Keflex
- Poland · Cefaleksyna Tzf
- Romania · Cefalexină Arena, Cefalexina Atb
- Slovakia · Ospexin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9a5028a-6d84-436a-892c-f454ba0d293d GET /v1/drugs/d9a5028a-6d84-436a-892c-f454ba0d293d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "OBN7UDS42Y",
"rxcui": "215948",
"inchikey": "AVGYWQBCYZHHPN-CYJZLJNKSA-N",
"display_name": "CEPHALEXIN",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 2
},
"spl_meta": {
"4ecf9314-76e2-c270-e063-6294a90ad8db": {
"match": "brand_token",
"title": "CEPHALEXIN CAPSULE [NORTHWIND HEALTH COMPANY, LLC]",
"spl_version": "2",
"published_date": "2026-05-25"
}
},
"productid": "72789-251_40ad376a-ff01-ce39-e063-6294a90a7174",
"productndc": "72789-251",
"dosage_form": "CAPSULE",
"orange_book": {
"appl_no": "090836",
"products": [
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 250MG BASE",
"product_no": "001",
"approval_date": "Dec 20, 2010"
},
{
"rs": false,
"rld": false,
"te_code": "AB",
"strength": "EQ 500MG BASE",
"product_no": "002",
"approval_date": "Dec 20, 2010"
},
{
"rs": false,
"rld": false,
"te_code": null,
"strength": "EQ 333MG BASE",
"product_no": "003",
"approval_date": "Mar 29, 2013"
},
{
"rs": true,
"rld": false,
"te_code": "AB",
"strength": "EQ 750MG BASE",
"product_no": "004",
"approval_date": "Mar 29, 2013"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "CEPHALEXIN",
"proprietary_name": "Cephalexin",
"active_ingred_unit": "mg/1",
"application_number": "ANDA090836",
"marketing_category": "ANDA",
"nonproprietary_name": "Cephalexin",
"start_marketing_date": "20110119",
"active_numerator_strength": "500"
}See everything about cefalexin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.